Search Results 1371-1380 of 20017 for Hepatitis b

1. Adalimumab-atto (subcutaneous route) - Side effects & dosage - Mayo Clinic

   Granulomatosis polyangiitis—Use with caution. May increase the chance of getting new cancers. Diabetes or; Hepatitis B, history of or; Opportunistic infections, ...

2. Study of ISB 1342, a CD38/​CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma - Mayo Clinic

   - Seronegative for hepatitis B antigen; positive hepatitis B tests can be further evaluated by confirmatory tests, and if viral load is negative, the ...

3. A Study To Assess Efficacy And Safety Of Pembrolizumab With Or Without Sacituzumab Tirumotecan (MK- 2870) In Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019) - Mayo Clinic

   * Participants who are hepatitis B surface antigen (HBsAg) positive are eligible if they have received hepatitis B virus (HBV) antiviral therapy for at ...

4. A Study Of Obeticholic Acid Evaluating Clinical Outcomes In Patients With Primary Biliary Cirrhosis

   Hepatitis B or C virus infection; Primary sclerosing cholangitis; Alcoholic liver disease; Definite autoimmune liver disease or overlap hepatitis; Nonalcoholic ...

5. Surgery - Doctors - Mayo Clinic

   , Hepatitis C, Wilson's disease, Hepatitis B, Hepatocellular carcinoma, Primary biliary cholangitis, Nonalcoholic fatty liver disease, Cirrhosis, Autoimmune ...

6. A Study Assessing HMB-002 In Participants With Von Willebrand Disease - Mayo Clinic

   In Part B of the study, the safety and tolerability of repeat dosing will ... Has a positive test for Hepatitis B surface antigen (HbsAg), Hepatitis C ...

7. Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production - Mayo Clinic

   C virus or hepatitis B virus including: Chronic or active hepatitis B as diagnosed by serologic tests. In equivocal cases, hepatitis B or C polymerase chain ...

8. A Study to Evaluate the Effectiveness, Safety, and Tolerability of TAK-935 as an Adjunctive Therapy in Pediatric Patients with Developmental and/or Epileptic Encephalopathies - Mayo Clinic

   ... hepatitis B, or active hepatitis C infection. (Note that patients who have been vaccinated against hepatitis B [hepatitis B surface antibody {Ab}-positive] ...

9. Study of Treg Therapy in Subclinical Inflammation in Kidney Transplantation (TASK) - Mayo Clinic

   Positive HB surface antibody, negative HB core antibody and negative HB surface antigen for recipients immune to hepatitis B;; Negative HB surface antibody ...

10. A Study Of Ritlecitinib In Adults With Hidradenitis Suppurativa, Or HS - Mayo Clinic

    Infected with hepatitis B or hepatitis C viruses: all participants will undergo screening for hepatitis B and C for eligibility. Hepatitis B: At Screening ...